IBSA France
Michael Scully has had extensive work experience in the pharmaceutical industry. Michael currently holds the position of Head of US Commercial at IBSA Pharma. Prior to this, they served as the US Commercial Director at Luye Lifesciences USA from 2018 to 2022, where they led the commercial operations for the Luye portfolio and Latin America markets. Michael also held the role of Regional Sales Director at Vernalis Therapeutics from 2017 to 2018. Earlier in their career, Michael worked at AstraZeneca for several years in various roles, including US HCP Marketing Leader and Commercial Business Director. Michael was responsible for leading the scientific communications and HCP digital marketing for the Respiratory Portfolio at AstraZeneca. Michael also managed sales teams and improved performance in different underperforming regions. Overall, Michael Scully has a strong background in pharmaceutical sales and commercial leadership.
Michael Scully earned a Bachelor of Arts (BA) degree in History from Saint Michael's College from 1987 to 1991. Michael later pursued an MBA in Marketing from the University of Connecticut School of Business, completing their studies from 2003 to 2006.
This person is not in any teams
This person is not in any offices
IBSA France
IBSA Pharma S.A.S is the French subsidiary of IBSA, an international pharmaceutical group based in Switzerland. Created in 1987 under the Laboratoires Genevrier entity in the heart of Sophia-Antipolis, the first European technology park, IBSA Pharma has developed in 8 areas of specialization and provides patients and healthcare professionals with more than 100 pharmaceutical products, all manufactured in Europe according to the highest quality standards. Focused on innovation and driven by the desire to bring therapeutic alternatives to as many people as possible, the IBSA group is committed to improving the quality of life of patients by offering them health products in their best galenic form, for a proven and increased efficiency. IBSA Pharma is based on the 4 ethical and sustainable pillars of the group: #person, #innovation, # quality and # responsibility.